Cancer Weekly articles from July 2002

Cancer Weekly archives from July 2002

Enzyme may compound the spread of breast cancer in women.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Cyclo-oxygenase (COX)-2, an enzyme well-known for aggravating arthritis, may also be responsible for facilitating the spread of breast cancers. That's...

Tumor oxygenation could improve the efficiency of anticancer agents.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Hypoxia, a condition of reduced oxygen, now appears to extend the way it supports tumor survival further than just the way it modulates vascular endothelial...

Filgrastim is beneficial after stem cell transplantation.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Spain say that filgrastim (granulocyte colony-stimulating factor, or G-CSF) treatment can help breast cancer patients recover from hematopoietic...

Vaccines targeting carcinoembryonic antigen under investigation.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Scientists in Canada find carcinoembryonic antigen (CEA) an attractive target for cancer vaccines because T-lymphocytes are able to lyse tumor cells...

New fully endoscopic treatment for olfactory groove meningiomas.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- A Duncanville, Texas, construction manager is one of the first in Texas to have an olfactory groove meningioma removed in a minimally invasive procedure at Cedars-Sinai Medical Center's Skull Base...

Gene gun method feasible for transferring genes to human prostate cancers.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The gene gun method is useful for transferring genes to prostate cancer cell lines, scientists recently announced. According to a report in the June 2002...

Gene link discovered.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- In a study published in the June 6, 2002, issue of the journal Oncogene, researchers at Duke University Medical Center have identified the first gene known to be highly correlated to testicular cancer....

Aranesp studies explore potential of new anemia treatment paradigms.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- Clinical data from four Aranesp (darbepoetin alfa) studies presented at the 38th annual meeting of the American Society of Clinical Oncology (ASCO) suggest new potential dosing approaches for treating...

Angiostatin, radiation therapy safe as a combination cancer treatment.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc. (ENMD), released phase I clinical data that Angiostatin, when combined with radiation therapy, is safe with no dose-limiting toxicity in patients with cancers that require radiation...

Addition of chemotherapy to herceptin improves response rate.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- The addition of weekly Taxol (paclitaxel) plus Paraplatin (carboplatin) to Herceptin (trastuzamab) improves patient response and disease control in metastatic breast cancer that overexpresses the HER2...

Anastrozole eases concerns for women taking hormonal treatment for breast cancer.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- New results from the landmark ATAC (Arimidex, Tamoxifen Alone or in Combination) study show that treatment of early breast cancer with anastrozole almost halved the number of women developing...

FDA approves upgrade for Second Look computer-aided detection system.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- CADx Medical Systems Inc. announced that the U.S. Food and Drug Administration (FDA) approved a supplement for the Second Look computer aided detection (CAD) system for mammography. Second Look is...

Zometa is important advance in treating lung cancer-related complications.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- Study results demonstrating that Zometa (zoledronic acid for injection) delays the initial onset of bone complications by more than two months in patients with non-small cell lung cancer and other solid...

Cancer patients enrolled in trials do better when they receive palliative care.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- Contrary to common wisdom, cancer treatment is not disrupted - but may be enhanced - when interventions designed to improve patients' physical, functional, emotional and social well-being are provided...

Separation of targeting step from therapy step allows improved delivery.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- Immunomedics, Inc. (IMMU) announced that three abstracts published or presented at the 38th annual meeting of the American Society for Clinical Oncology, held in Orlando, Florida, reported advances by...

Frequent dosing of cancer agents could augment antiangiogenic therapies.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Low doses of potent chemotherapies given over long periods of time could prove more effective for destroying tumors, especially when they are used in...

AstraZeneca announces results for ZD1839 in advanced head and neck cancer.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- Data presented from the first phase II trial of ZD1839 (IRESSA) in patients with recurrent, advanced squamous cell cancer of the head and neck, whose disease had progressed following radiation and/or...

Clinical trial results in clinical plan for use of thalidomide.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- At the 38th annual meeting of the American Society of Clinical Oncology (ASCO), leading oncology teams from around the country presented data from clinical trials evaluating Thalomid (thalidomide) in...

Neovastat's favorable safety profile in phase III trials confirmed by DSMB.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- AEterna Laboratories, Inc. (AELA} announced the positive completion of safety analysis of its two phase III trials in renal cell carcinoma and non-small cell lung cancer conducted with Neovastat. ...

Erbitux combined with docetaxel in advanced non-small cell lung cancer.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- ImClone Systems, Inc., (IMCL) and Bristol-Myers Squibb (BMY) announced data from a study of the investigational monoclonal antibody Erbitux (cetuximab) in combination with docetaxel. Data showed the...

Allos updates phase II study results in non-small cell lung cancer at ASCO.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc. (ALTH) announced updated positive survival results from a phase II clinical trial evaluating the use of RSR13 (efaproxiral) in patients with locally advanced, unresectable,...

Gene expression improves success of melanoma vaccine.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Expression of at least two of the five HLA class I antigens increased relapse-free survival rates of patients who receive an allogeneic tumor vaccine...

Gene for syntenin is overexpressed in metastatic breast and gastric cancers.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Medical researchers in Korea have identified the gene for a protein that appears to correlate with the spread of some cancers. The gene for syntenin is...

Human Genome Sciences describes activity of new cancer drug.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc. (HGSI) announced that preclinical data presented at the 38th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, supports the successful...

Sperm antigen 17 shows promise for ovarian cancer therapy.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - A vaccine directed against sperm antigen 17 showed potential as a successful treatment for ovarian cancer, researchers in Texas report. The...

Early detection of pancreatic cancer in diabetic patients difficult.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, staff medical writer - Endoscopic retrograde pancreatography (ERP) detected pancreatic carcinoma in high-risk diabetic patients, but the condition was advanced, indicating...

Stanford researcher advocates aggressive, preventive anal cancer treatment.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- Rates of cervical cancer dropped by 78% once women started receiving yearly Pap smears in the 1940s. Now Mark Welton, MD, associate professor of surgery at Stanford University Medical Center, hopes to...

Monoclonal antibody treatment shown to be safe, well tolerated.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- Posters evaluating two clinical trials of YM BioSciences Inc.'s TheraCIM, a humanized monoclonal antibody (MAb) to EGFr (h-R3), in patients with locally advanced squamous cell cancer of the head and...

Synergy of combination gene therapy may be better for treating tumors.(Brief Article)
July 2, 2002... 2002 JUL 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Scientists in Canada have developed a powerful mix of gene therapies that may work better to fight cancer. Incorporating two cytokines, interferon...

Strategy of eliminating Stat5a might reduce breast cancer cell survival.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Murine model experiments suggest Stat5a gene activation promotes breast cancer. Researchers now think that by decreasing the activity of this gene, breast...

Reactive stroma regulates neovascularization in prostate tumors.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Given the way stromal cells in prostate cancer tumors regulate growth mechanisms, they could be targeted for therapeutic control, researchers at Baylor College...

Selective enzyme inhibitor NS-398 arrests the growth of liver cancer cells.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Primary liver cancer is one of the most common forms of cancer in the world. A new Japanese study indicates the growth of liver cancer cells could be arrested...

Trojan horse drug duo destroys tumors' blood supply.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- Researchers have demonstrated in mice that a new drug formed by linking a vascular endothelial growth factor to a toxin will target and destroy the blood vessels supplying a malignant tumor. The...

Natural resistance of pigment cells to sunlight may make deadly skin cancer tough to treat.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- Scientists at Dana-Farber Cancer Institute have discovered that a gene that enables the skin's pigmented cells to survive harsh sunlight may have a darker side as well: making the deadly skin cancer,...

Flavopiridol an angiogenic modulator in tumors affecting children.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The enzyme inhibitor flavopiridol can arrest angiogenesis in human neuroblastoma, researchers at the Giannina Gaslini Institute in Genoa, Italy have determined....

Vasculogenic mimicry in breast cancer a factor for recurrence and lower survival.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Building on the work of an earlier study, researchers in Japan have produced evidence supporting of the role of vasculogenic mimicry in breast cancer recurrence...

Cells expressing granulocyte macrophage-colony stimulating factor prevent gliosarcomas.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Tumor cells expressing granulocyte macrophage-colony stimulating factor (GM-CSF) showed feasibility as an adjuvant for vaccines against...

Green tea extracts may be useful in treating smoking-related cancer.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Green tea extracts functioned as a chemopreventive agent on an in vitro bladder cancer model, according to a new study presented by Allan J. Pantuck, MD, visiting...

Concurrent chemotamoxifen halves benefit of chemotherapy.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Janis Kelly, senior medical writer - Results of a major, long-term study presented at the 38th Annual Meeting of the American Society of Clinical Oncology in Orlando, Florida, are expected to...

Research into rare disease leads to discovery of six new breast cancer-susceptibility genes.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- A decade of research into one of the world's least-known diseases has resulted in a major advance against one of the best-known: the discovery of six genes linked to inherited breast cancer. In a...

Prophylactic salpingo-oophorectomy reduces risk.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Researchers have shown, for the first time, that women who face an increased risk of breast and ovarian cancer because of mutations in BRCA1 and BRCA2 genes can...

Standard therapy better for head and neck cancer patients.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Head and neck cancer patients who receive a combination of radiation and chemotherapy after surgery do not have significantly lower rates of local cancer...

Novel agent ZD6126 selective for vessels in tumor destruction.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - New findings in animal model experiments point to the novel vascular targeting agent ZD6126 as being selective for destroying tumor vessels in several...

Heat shock protein 70 protects against methylcholanthrene-induced sarcomas.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Immunization with heat shock protein 70 prevented development of methylcholanthrene-induced sarcomas in mice, according to researchers at Karolinska...

Study shows how fish oil nutrients reduce risk.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- For years, scientists have recognized that nutrients known as omega-3 fatty acids, which are commonly found in fish oil, offer significant protection against colon cancer. Now, researchers at the...

Possible link to dietary habits found.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- Scientists funded by the U.S. Agricultural Research Service (ARS) recently studied dietary habits that might ward off esophageal cancer, a form so deadly only about 12% of those diagnosed survive 5...

STI-571 proves a durable weapon against some gastric cancers.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Janis Kelly, senior medical writer - The striking benefits of STI-571 (imatinib mesylate, Gleevec) reported last year in patients with unresectable and metastatic gastrointestinal stromal tumors...

Intensification therapy studied.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- Patients with advanced head and neck cancers may stand a better chance of long-term disease control if they are willing to undergo "intensification therapy," a complex regimen of surgery, radiation and...

Anti-EGF drug shrinks tumors, relieves symptoms.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Janis Kelly, senior medical writer - Locking a tyrosine kinase up inside cancer cells can help stabilize disease and relieve symptoms even in very advanced, treatment-refractory lung cancer. ...

Genetic aberrations link studied.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- Researchers at Ohio State University have identified more than two dozen genes that behave abnormally in cancerous lung cells. The finding could lead to new tests for diagnosing lung cancer. Led...

Taxotere (docetaxel) and platinum combination provide quality of life advantage as first-line treatment.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- A chemotherapy regimen that combines Taxotere (docetaxel) for Injection Concentrate with a platinum compound leads to a significantly better quality of life than the combination of vinorelbine...

Vitamin A derivative shows early promise in cancer prevention.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - A cousin of vitamin A may be able to reverse some precancerous changes in the lungs of former smokers. The results, presented at the 38th Annual Meeting of the...

Tobacco money: Up in smoke?(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- Dartmouth Medical School and Veterans Affairs physicians criticize the $10 million research program financed mainly by New York's tobacco settlement fund in the Lancet June 15, 2002. The program...

Study suggests combination treatment.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Combination chemotherapy with carboplatin plus paclitaxel increases response rates of non-small cell lung cancer (NSCLC) patients, helps more of them survive the...

New data: Taxotere/carboplatin as effective and less neurotoxic than standard therapy.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- The anticancer drug combination of Taxotere (docetaxel) and carboplatin demonstrated less neurotoxicity and was equally effective as the standard treatment of paclitaxel and carboplatin when used as...

Lorus receives fast track designation from FDA for Virulizin.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- Lorus Therapeutics, Inc., (Lorus) announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for Virulizin in the treatment of pancreatic cancer. Virulizin is the...

New test identifies aggressive and less aggressive forms.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- A simple test can be used to identify patients with the most aggressive prostate cancers, even among patients whose tumors are at the same stage, according to research at the University of Minnesota....

Research: Early hormonal therapy beneficial for radical prostatectomy patients.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- New data indicates that prostate cancer patients who have had radical prostatectomy benefit significantly from early hormonal therapy. Hormonal therapy given for prostate specific antigen (PSA)-only...

Yearly PSA not needed for most men.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Janis Kelly, senior medical writer - Most men do not need yearly prostate specific antigen (PSA) screening, and many can safely defer testing to once every 5 years, researchers reported. E....

Young cigarette smokers have more aggressive disease.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Lynn Yoffee, senior medical writer - Few people make the link between cigarette smoking and prostate cancer. But the habit is linked to aggressive forms of prostate cancer, according to a new study...

Continued smoking halves efficacy of small cell lung cancer treatment.(Brief Article)
July 9, 2002... 2002 JUL 9 - (NewsRx.com & NewsRx.net) -- by Janis Kelly, senior medical writer - Patients with limited stage small cell lung cancer (confined to the chest) have a slight but real chance of cure with chemoradiotherapy. That chance shrinks by...

Nerve growth factor may play some role in tumor vascularity.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - According to scientists in Japan, nerve growth factor (NGF) may be responsible, at least in part, for tumor angiogenesis in hepatocellular carcinoma (HCC), a...

WT1 useful as pediatric disease marker.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The WT1 gene is useful for determining disease progression in pediatric leukemia patients, researchers in the United States report. "WT1 encodes a...

Overproduction of ErbB2 possibly linked to angiogenesis in breast cancer.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Typically, the receptor ErbB2 dos not cause problems when expressed at normal levels. However, when overexpressed, it can ignite the development of cancer....

STI-571 emerges as new standard of care for early and advanced CML.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- by Janis Kelly, senior medical writer - Imatinib (STI-571, Gleevec) is so much better than interferon for newly diagnosed chronic myeloid leukemia (CML) that it should now be considered the standard of...

Combined PET/CT finds cancerous lesions standard CT misses.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- If more doctors had access to a combined PET/CT scanner to examine patients with ovarian or cervical carcinomas, they would likely catch cancerous lesions that would not be found by CT (computed...

Cell phones don't cause cancer, rats study finds.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- Radiation from cell phones doesn't appear to cause cancer in rats, according to a study by researchers at Washington University School of Medicine in St. Louis, Missouri. The research team exposed...

Researchers developing technology to outsmart metastasized cancers.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- News that a malignant tumor has spread to other parts of the body seems like a death knell to the ears of many cancer patients. But Endocyte, Inc., and Purdue University researchers are developing...

Ritonavir can reduce Kaposi sarcoma risk.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The antiretroviral agent ritonavir may help prevent the development of Kaposi sarcoma (KS) in HIV patients, researchers in the United States report. ...

Protective genetic factors identified.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States and Europe have identified several genetic risk factors for the development of acute lymphocytic leukemia (ALL). "We...

Mortality may be tied to prolonged exposure to low-dose radiation.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- Women who worked as radiation technologists before 1950 have a higher risk of dying from breast cancer than those who began working in more recent years, reported Aparna K. Mohan, MD, PhD, now with the...

Study finds that 9% of patients had delay in diagnosis.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- Among patients with breast cancer, 9% had a delay in diagnosis, with inappropriate reassurance that a breast mass is benign without taking a biopsy, the leading cause of physician-related delays,...

Unprecedented survival results with combination oral Xeloda and Taxotere.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- The authors of a publication in the Journal of Clinical Oncology (2002;20(12):2812-2823) conclude that a study of over 500 women with metastatic breast cancer demonstrates that the combination of...

Study reports ETG prevents CMF chemotherapy induced hair loss.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- Current Technology Corporation (CRTCF) announced Psycho-Oncology's publication, (2002;11:244-248) of the results of a pilot research study that examined whether ETG (electrotrichogenesis) could...

STI571 reduces proliferative advantage of malignant progenitor cells.(Imatinib mesylate (STI571))(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have shed new light on the mechanisms of a powerful and novel treatment for leukemia. "Imatinib mesylate (STI571) is a...

Clinical development programs advanced.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- Essential Therapeutics, Inc., (ETRX) announced its plans to initiate three new phase II clinical trials in the areas of hematology/oncology and infectious diseases. These three studies are...

Soluble receptor competes with adenoviral-based gene delivery to tumors.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Competition between adenoviruses and soluble receptors in the tumor environment may compromise gene transfer, scientists have determined. Malignant...

Research grant awarded to advance cancer treatment drug delivery system.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc., (CRY), a life-science company involved in the development and commercialization of cryopreserved and tissue-engineered implantable heart valves, vascular and orthopedic grafts, and...

Phase III trial of Neovastat set for 2003.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- At the annual general meeting of AEterna Laboratories, Inc., (AEL, AELA) Eric Dupont, chairman of the board and CEO, told the shareholders that "Our phase III clinical study of Neovastat in kidney...

Gene test predicts survival.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- Cancer researchers have devised a genetic test that can accurately predict the survival chances of patients with some aggressive forms of lymphoma. The test yielded a genetically based survival...

Phase III trial initiated comparing Velcade with high-dose dexamethasone.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- Millennium Pharmaceuticals, Inc., (MLNM) initiated a phase III clinical trial of Velcade (formerly known as MLN341, LDP-341 and PS-341) in patients with multiple myeloma. The company also announced...

Inflammation before liver cancer surgery influences outcomes in hepatitis C.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Physicians can use scores on liver evaluations to determine the odds for recurrence after treating their patients with hepatitis C virus (HCV)-related...

Genetically modified tomato packs more cancer-fighting punch.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- Forget the attack of the killer tomato, this is the attack of the healthy tomato: A team of scientists has developed a tomato that contains as much as three and a half time more of the cancer-fighting...

Vitamin E study is called 'tremendously significant' in search for cure.(Brief Article)
July 16, 2002... 2002 JUL 16 - (NewsRx.com & NewsRx.net) -- Nutritional supplements such as vitamin E may be able to stop prostate cancer before it starts, according to health researchers. They point to a major new trial involving 30,000 men to study the...